Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties

Predictive value of FDG PET at initial radioiodine therapy for survival of high-risk patients with differentiated thyroid cancer

Florian Gaertner, Shozo Okamoto, Tohru Shiga, Yoichi Ito, Yuko Uchiyama, Osamu Manabe, Naoya Hattori and Nagara Tamaki
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 146;
Florian Gaertner
1Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shozo Okamoto
1Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tohru Shiga
1Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoichi Ito
2Department of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuko Uchiyama
1Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osamu Manabe
1Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoya Hattori
1Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nagara Tamaki
1Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 55 no. supplement 1 146

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 5, 2014.

Copyright & Usage 
© 2014

Author Information

  1. Florian Gaertner1,
  2. Shozo Okamoto1,
  3. Tohru Shiga1,
  4. Yoichi Ito2,
  5. Yuko Uchiyama1,
  6. Osamu Manabe1,
  7. Naoya Hattori1 and
  8. Nagara Tamaki1
  1. 1Department of Nuclear Medicine, Hokkaido University Graduate School of Medicine, Sapporo, Japan
  2. 2Department of Biostatistics, Hokkaido University Graduate School of Medicine, Sapporo, Japan

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: November 2014 to April 2025

AbstractFullPdf
Nov 2014100
Dec 2014200
Jan 2015500
Feb 2015100
Apr 2015200
May 2015200
Aug 2015700
Sep 2015300
Dec 2015200
Mar 2016100
Jun 2016300
Jul 2016100
Aug 20161500
Oct 2016200
Nov 2016100
Dec 2016300
Feb 2017100
Mar 2017100
May 2017200
Jun 2017300
Jul 2017300
Aug 2017200
Sep 2017100
Oct 2017600
Nov 2017200
Mar 2018200
Apr 2018300
May 2018100
Jul 2018200
Oct 2018100
Dec 2018200
Jul 2019100
Sep 2019100
Dec 2019200
Feb 2020500
Mar 20201400
Apr 2020800
Jul 2020400
Aug 20201300
Sep 20202900
Oct 20201100
Nov 20201700
Dec 20201000
Jan 2021300
Feb 2021600
Mar 2021700
Apr 2021900
May 2021500
Jun 2021200
Jul 20211500
Aug 20213100
Sep 20211000
Oct 20211100
Nov 20215700
Dec 20213500
Jan 20227000
Feb 20221700
Mar 20221100
Apr 2022900
May 20222600
Jun 2022500
Jul 2022100
Aug 2022500
Sep 2022300
Oct 2022100
Nov 2022200
Dec 2022100
Jan 2023200
Feb 2023100
Mar 2023500
Apr 2023200
May 2023100
Jun 2023300
Jul 2023100
Aug 2023200
Sep 2023400
Oct 2023100
Nov 2023300
Dec 2023300
Jan 2024600
Feb 2024100
Mar 2024100
Apr 2024100
May 2024300
Jun 2024200
Aug 20241300
Sep 2024900
Nov 2024600
Dec 2024700
Jan 2025100
Feb 2025200
Mar 2025200
Apr 2025500
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 55, Issue supplement 1
May 2014
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Predictive value of FDG PET at initial radioiodine therapy for survival of high-risk patients with differentiated thyroid cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Predictive value of FDG PET at initial radioiodine therapy for survival of high-risk patients with differentiated thyroid cancer
Florian Gaertner, Shozo Okamoto, Tohru Shiga, Yoichi Ito, Yuko Uchiyama, Osamu Manabe, Naoya Hattori, Nagara Tamaki
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 146;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Predictive value of FDG PET at initial radioiodine therapy for survival of high-risk patients with differentiated thyroid cancer
Florian Gaertner, Shozo Okamoto, Tohru Shiga, Yoichi Ito, Yuko Uchiyama, Osamu Manabe, Naoya Hattori, Nagara Tamaki
Journal of Nuclear Medicine May 2014, 55 (supplement 1) 146;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties

  • The Role of 18F-NaF PET/CT imaging in diagnosis and management of familial tumoral calcinosis – A pictorial review
  • Assessing the role of FDG- and NaF-PET/CT in evaluating inflammatory spine disorders
  • Quantitative analysis of COVID-19 associated inflammation using FDG-PET/CT
Show more General Clinical Specialties

INTEGRATED Session: Advance Management of Thyroid Cancer

  • What is the impact of pre-ablation 131-I scintigraphy with SPECT-CT on thyroid cancer management?
  • Radioactive iodine-131 induces human thyrocyte cell line HTori 3 cell apoptosis and G2/M arrest in a p53-independent pathway
  • Salivary gland scintigraphy to detect chronic salivary gland damages after high dose radioiodine therapy for thyroid cancer: Correlation with sialography
Show more INTEGRATED Session: Advance Management of Thyroid Cancer

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire